The pituitary stalk interruption syndrome market is expanding due to increased early diagnosis, adoption of growth hormone therapy, and advancements in endocrine imaging and rare disease care. https://www.datamintelligence.com/research-report/pituitary-stalk-interruption-syndrome-market